A citation-based method for searching scientific literature

Fei Zhou, Meng Qiao, Caicun Zhou. Cell Mol Immunol 2021
Times Cited: 8







List of co-cited articles
7 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants.
Pedram Razavi, Bob T Li, David N Brown, Byoungsok Jung, Earl Hubbell, Ronglai Shen, Wassim Abida, Krishna Juluru, Ino De Bruijn, Chenlu Hou,[...]. Nat Med 2019
200
25

Detection of circulating tumor DNA in early- and late-stage human malignancies.
Chetan Bettegowda, Mark Sausen, Rebecca J Leary, Isaac Kinde, Yuxuan Wang, Nishant Agrawal, Bjarne R Bartlett, Hao Wang, Brandon Luber, Rhoda M Alani,[...]. Sci Transl Med 2014
25

Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors.
Zhijie Wang, Jianchun Duan, Guoqiang Wang, Jing Zhao, Jiachen Xu, Jiefei Han, Zhengyi Zhao, Jun Zhao, Bo Zhu, Minglei Zhuo,[...]. J Thorac Oncol 2020
26
25

Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate.
Shumei Kato, Aaron Goodman, Vighnesh Walavalkar, Donald A Barkauskas, Andrew Sharabi, Razelle Kurzrock. Clin Cancer Res 2017
471
25

Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab.
David R Gandara, Sarah M Paul, Marcin Kowanetz, Erica Schleifman, Wei Zou, Yan Li, Achim Rittmeyer, Louis Fehrenbacher, Geoff Otto, Christine Malboeuf,[...]. Nat Med 2018
507
25

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
25

Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC.
Roy S Herbst, Giuseppe Giaccone, Filippo de Marinis, Niels Reinmuth, Alain Vergnenegre, Carlos H Barrios, Masahiro Morise, Enriqueta Felip, Zoran Andric, Sarayut Geater,[...]. N Engl J Med 2020
188
25

A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment.
Arabella Young, Shin Foong Ngiow, Yulong Gao, Ann-Marie Patch, Deborah S Barkauskas, Meriem Messaoudene, Gene Lin, Jerome D Coudert, Kimberley A Stannard, Laurence Zitvogel,[...]. Cancer Res 2018
124
12

Pharmacology and therapeutic applications of A3 receptor subtype.
Pnina Fishman, Sara Bar-Yehuda. Curr Top Med Chem 2003
70
12

Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma.
Qiming Zhang, Yao He, Nan Luo, Shashank J Patel, Yanjie Han, Ranran Gao, Madhura Modak, Sebastian Carotta, Christian Haslinger, David Kind,[...]. Cell 2019
239
12

Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells.
Benjamin Ruf, Bernd Heinrich, Tim F Greten. Cell Mol Immunol 2021
21
12

A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application.
Taku Okazaki, Shunsuke Chikuma, Yoshiko Iwai, Sidonia Fagarasan, Tasuku Honjo. Nat Immunol 2013
541
12

A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti-PD-(L)1 and Anti-CTLA-4 in Preclinical Models.
Stephen B Willingham, Po Y Ho, Andrew Hotson, Craig Hill, Emily C Piccione, Jessica Hsieh, Liang Liu, Joseph J Buggy, Ian McCaffery, Richard A Miller. Cancer Immunol Res 2018
74
12


Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.
Pascale André, Caroline Denis, Caroline Soulas, Clarisse Bourbon-Caillet, Julie Lopez, Thomas Arnoux, Mathieu Bléry, Cécile Bonnafous, Laurent Gauthier, Ariane Morel,[...]. Cell 2018
401
12

Immune checkpoint blockade: a common denominator approach to cancer therapy.
Suzanne L Topalian, Charles G Drake, Drew M Pardoll. Cancer Cell 2015
12

Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing.
Dirk Heckl, Monika S Kowalczyk, David Yudovich, Roger Belizaire, Rishi V Puram, Marie E McConkey, Anne Thielke, Jon C Aster, Aviv Regev, Benjamin L Ebert. Nat Biotechnol 2014
295
12

Nucleosome-interacting proteins regulated by DNA and histone methylation.
Till Bartke, Michiel Vermeulen, Blerta Xhemalce, Samuel C Robson, Matthias Mann, Tony Kouzarides. Cell 2010
393
12

The Sequence Alignment/Map format and SAMtools.
Heng Li, Bob Handsaker, Alec Wysoker, Tim Fennell, Jue Ruan, Nils Homer, Gabor Marth, Goncalo Abecasis, Richard Durbin. Bioinformatics 2009
12

KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling.
Klaus W Wagner, Hunain Alam, Shilpa S Dhar, Uma Giri, Na Li, Yongkun Wei, Dipak Giri, Tina Cascone, Jae-Hwan Kim, Yuanqing Ye,[...]. J Clin Invest 2013
114
12

Inhibition of Casein Kinase 1 Alpha Prevents Acquired Drug Resistance to Erlotinib in EGFR-Mutant Non-Small Cell Lung Cancer.
Alexandra B Lantermann, Dongshu Chen, Kaitlin McCutcheon, Greg Hoffman, Elizabeth Frias, David Ruddy, Daniel Rakiec, Joshua Korn, Gregory McAllister, Frank Stegmeier,[...]. Cancer Res 2015
27
12

Changing paradigm in advanced and metastatic non-small cell lung cancer.
Dipesh Uprety, Kaushal Parikh, Anita Sawkar, Anastasios Dimou, Konstantinos Leventakos. J Thorac Dis 2020
2
50

History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature.
Chiara Lazzari, Aurora Mirabile, Alessandra Bulotta, Maria Grazia Viganó, Francesca Rita Ogliari, Stefania Ippati, Italo DellOca, Mariacarmela Santarpia, Vincenza Lorusso, Martin Reck,[...]. Cancers (Basel) 2021
2
50

Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases.
Nathan R Rose, Esther C Y Woon, Anthony Tumber, Louise J Walport, Rasheduzzaman Chowdhury, Xuan Shirley Li, Oliver N F King, Clarisse Lejeune, Stanley S Ng, Tobias Krojer,[...]. J Med Chem 2012
81
12

Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells.
Robin M Meyers, Jordan G Bryan, James M McFarland, Barbara A Weir, Ann E Sizemore, Han Xu, Neekesh V Dharia, Phillip G Montgomery, Glenn S Cowley, Sasha Pantel,[...]. Nat Genet 2017
559
12

An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma.
Francesca Reggiani, Elisabetta Sauta, Federica Torricelli, Eleonora Zanetti, Elena Tagliavini, Giacomo Santandrea, Giulia Gobbi, Giovanna Damia, Riccardo Bellazzi, Davide Ambrosetti,[...]. Mol Cancer 2021
1
100

Casein kinase 1 and Wnt/β-catenin signaling.
Cristina-Maria Cruciat. Curr Opin Cell Biol 2014
71
12

ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks.
Gabriela Bindea, Bernhard Mlecnik, Hubert Hackl, Pornpimol Charoentong, Marie Tosolini, Amos Kirilovsky, Wolf-Herman Fridman, Franck Pagès, Zlatko Trajanoski, Jérôme Galon. Bioinformatics 2009
12

Fast gapped-read alignment with Bowtie 2.
Ben Langmead, Steven L Salzberg. Nat Methods 2012
12

The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells.
Giulia Gobbi, Benedetta Donati, Italo Faria Do Valle, Francesca Reggiani, Federica Torricelli, Daniel Remondini, Gastone Castellani, Davide Carlo Ambrosetti, Alessia Ciarrocchi, Valentina Sancisi. Oncogene 2019
28
12

Cytoscape: a software environment for integrated models of biomolecular interaction networks.
Paul Shannon, Andrew Markiel, Owen Ozier, Nitin S Baliga, Jonathan T Wang, Daniel Ramage, Nada Amin, Benno Schwikowski, Trey Ideker. Genome Res 2003
12

DGIdb 3.0: a redesign and expansion of the drug-gene interaction database.
Kelsy C Cotto, Alex H Wagner, Yang-Yang Feng, Susanna Kiwala, Adam C Coffman, Gregory Spies, Alex Wollam, Nicholas C Spies, Obi L Griffith, Malachi Griffith. Nucleic Acids Res 2018
322
12

Mediatory role of BLT2 in the proliferation of KRAS mutant colorectal cancer cells.
JaeIn Park, Jae-Hyun Jang, Jae-Hong Kim. Biochim Biophys Acta Mol Cell Res 2019
4
25

Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Katherine A Hoadley, Christina Yau, Toshinori Hinoue, Denise M Wolf, Alexander J Lazar, Esther Drill, Ronglai Shen, Alison M Taylor, Andrew D Cherniack, Vésteinn Thorsson,[...]. Cell 2018
685
12

Transcriptional repression of histone deacetylase 3 by the histone demethylase KDM2A is coupled to tumorigenicity of lung cancer cells.
Shilpa S Dhar, Hunain Alam, Na Li, Klaus W Wagner, Jimyung Chung, Yeo Won Ahn, Min Gyu Lee. J Biol Chem 2014
38
12


Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy.
M Gugnoni, V Sancisi, G Gandolfi, G Manzotti, M Ragazzi, D Giordano, I Tamagnini, M Tigano, A Frasoldati, S Piana,[...]. Oncogene 2017
109
12


Drugging the addict: non-oncogene addiction as a target for cancer therapy.
Remco Nagel, Ekaterina A Semenova, Anton Berns. EMBO Rep 2016
69
12

Altered Tnnt3 characterizes selective weakness of fast fibers in mice overexpressing FSHD region gene 1 (FRG1).
Valentina Sancisi, Elena Germinario, Alessandra Esposito, Elisabetta Morini, Samantha Peron, Maurizio Moggio, Giuliano Tomelleri, Daniela Danieli-Betto, Rossella Tupler. Am J Physiol Regul Integr Comp Physiol 2014
15
12

Next-generation characterization of the Cancer Cell Line Encyclopedia.
Mahmoud Ghandi, Franklin W Huang, Judit Jané-Valbuena, Gregory V Kryukov, Christopher C Lo, E Robert McDonald, Jordi Barretina, Ellen T Gelfand, Craig M Bielski, Haoxin Li,[...]. Nature 2019
703
12

DrugBank 5.0: a major update to the DrugBank database for 2018.
David S Wishart, Yannick D Feunang, An C Guo, Elvis J Lo, Ana Marcu, Jason R Grant, Tanvir Sajed, Daniel Johnson, Carin Li, Zinat Sayeeda,[...]. Nucleic Acids Res 2018
12

Histone demethylation by a family of JmjC domain-containing proteins.
Yu-ichi Tsukada, Jia Fang, Hediye Erdjument-Bromage, Maria E Warren, Christoph H Borchers, Paul Tempst, Yi Zhang. Nature 2006
12

Histone Deacetylase Inhibitors Repress Tumoral Expression of the Proinvasive Factor RUNX2.
Valentina Sancisi, Greta Gandolfi, Davide Carlo Ambrosetti, Alessia Ciarrocchi. Cancer Res 2015
22
12

Molecular histology of lung cancer: from targets to treatments.
Steven L Wood, Maria Pernemalm, Philip A Crosbie, Anthony D Whetton. Cancer Treat Rev 2015
114
12

A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer.
Gordana Vlahovic, Kellen L Meadows, Ace J Hatch, Jingquan Jia, Andrew B Nixon, Hope E Uronis, Michael A Morse, M Angelica Selim, Jeffrey Crawford, Richard F Riedel,[...]. Oncologist 2018
11
12

Comprehensive genomic profiles of small cell lung cancer.
Julie George, Jing Shan Lim, Se Jin Jang, Yupeng Cun, Luka Ozretić, Gu Kong, Frauke Leenders, Xin Lu, Lynnette Fernández-Cuesta, Graziella Bosco,[...]. Nature 2015
905
12

Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models.
Waleed Minzel, Avanthika Venkatachalam, Avner Fink, Eric Hung, Guy Brachya, Ido Burstain, Maya Shaham, Amitai Rivlin, Itay Omer, Adar Zinger,[...]. Cell 2018
58
12

Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities.
Kendall R Sanson, Ruth E Hanna, Mudra Hegde, Katherine F Donovan, Christine Strand, Meagan E Sullender, Emma W Vaimberg, Amy Goodale, David E Root, Federica Piccioni,[...]. Nat Commun 2018
157
12

Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer.
Lihui Li, Jihui Kang, Wenjuan Zhang, Lili Cai, Shiwen Wang, Yupei Liang, Yanyu Jiang, Xiaojun Liu, Yunjing Zhang, Hongfeng Ruan,[...]. EBioMedicine 2019
20
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.